Literature DB >> 2824663

Evidence that deletion of coding sequences in the 5' end of the thymidine kinase gene of herpes simplex virus type 1 affects the stability of the gene products.

L Haarr1, T Flatmark.   

Abstract

The experiments described in the present work were designed to study the function of the N-terminal end of thymidine kinase (TK) encoded by herpes simplex virus type 1. Specifically we were interested to know whether this end was involved in binding of the enzyme to other molecules, had any influence on its subcellular localization or affected one or more of the activities associated with the enzyme. A parental enzyme and a deletion mutant, lacking the 45 N-terminal amino acids, derived from this strain, were used. Thymidine kinase from the parental virus bound to DNA-Sepharose, but the truncated enzyme did not. This was apparently not due to a specific ability to bind to DNA, since immunofluorescence studies indicated that both the normal and the deleted TK were mainly located in the cytoplasm, preferentially in the perinuclear region. Phosphorylation of thymidine as well as the amounts of TK polypeptides were markedly reduced at late times after infection with the mutant, but not to the same extent after infection with the wild-type. The deleted TK gene was efficiently transcribed as shown by hybridization of RNA to a probe specific for the gene, and this RNA directed the synthesis in vitro of TK polypeptides. Deletion of the 5' end of the gene seems to affect the stability of either the enzyme or TK-specific mRNA, or both. The TMP phosphorylating activity seems to be particularly destabilized relative to the thymidine phosphorylating activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824663     DOI: 10.1099/0022-1317-68-11-2817

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Combination gene delivery of the cell cycle inhibitor p27 with thymidine kinase enhances prodrug cytotoxicity.

Authors:  X Danthinne; K Aoki; A L Kurachi; G J Nabel; E G Nabel
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

2.  Initiation of herpes simplex virus thymidine kinase polypeptides.

Authors:  A R Ellison; J O Bishop
Journal:  Nucleic Acids Res       Date:  1996-06-01       Impact factor: 16.971

3.  In-vitro synthesis of functional varicella zoster and herpes simplex viral thymidine kinase.

Authors:  R Mahalingam; G Cabirac; M Wellish; D Gilden; A Vafai
Journal:  Virus Genes       Date:  1990-07       Impact factor: 2.332

4.  The UL97 gene product of human cytomegalovirus is an early-late protein with a nuclear localization but is not a nucleoside kinase.

Authors:  D Michel; I Pavić; A Zimmermann; E Haupt; K Wunderlich; M Heuschmid; T Mertens
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Evolution of the herpes thymidine kinase: identification and comparison of the equine herpesvirus 1 thymidine kinase gene reveals similarity to a cell-encoded thymidylate kinase.

Authors:  G R Robertson; J M Whalley
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

6.  Differential intracellular compartmentalization of herpetic thymidine kinases (TKs) in TK gene-transfected tumor cells: molecular characterization of the nuclear localization signal of herpes simplex virus type 1 TK.

Authors:  B Degrève; M Johansson; E De Clercq; A Karlsson; J Balzarini
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

7.  A truncated herpes simplex virus thymidine kinase phosphorylates thymidine and nucleoside analogs and does not cause sterility in transgenic mice.

Authors:  B Salomon; S Maury; L Loubière; M Caruso; R Onclercq; D Klatzmann
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

8.  Rana grylio virus thymidine kinase gene: an early gene of iridovirus encoding for a cytoplasmic protein.

Authors:  Zhe Zhao; Fei Ke; Yan Shi; Guang-Zhou Zhou; Jian-Fang Gui; Qi-Ya Zhang
Journal:  Virus Genes       Date:  2009-01-06       Impact factor: 2.198

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.